Jafri Hasan 4/A
4/A · Aridis Pharmaceuticals, Inc. · Filed Jun 25, 2020
Insider Transaction Report
Form 4/AAmended
Jafri Hasan
Chief Medical Officer
Transactions
- Award
Stock Options
2020-06-25+80,000→ 80,000 totalExercise: $6.16Exp: 2030-06-25→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on the first year anniversary of the Vesting Commencement Date, which is June 15, 2020. Thereafter, 1/48th of the shares subject to the option shall vest each month on the same day of the month as the Vesting Commencement Date, subject to the Optionee providing services through each such vesting date (unless otherwise determined by the Company).